Search research articles
Contact Us
Filters
Showing results (111-120 of 284) with videos related to
Page
of 29
Sort By:
Pharmacoepidemiology and Drug Safety
|
November 22, 2016
Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment
Evans L Sagwa, Patrick C Souverein, Inês Ribeiro, et al.
Pharmacoeconomics
|
October 5, 2024
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability
Marcelien H E Callenbach, Rick A Vreman, Christine Leopold, et al.
Journal of Pharmaceutical Policy and Practice
|
January 11, 2024
Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children
E Petro, V Perumal-Pillay, A K Mantel-Teeuwisse, et al.
International Journal of Environmental Research and Public Health
|
November 13, 2020
Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis
Rick A Vreman, Thomas F Broekhoff, Hubert Gm Leufkens, et al.
Drug Safety
|
March 23, 2011
Today's challenges in pharmacovigilance: what can we learn from epoetins?
Hans C Ebbers, Aukje K Mantel-Teeuwisse, Ellen H M Moors, et al.
BMC Public Health
|
December 20, 2018
The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study
Tom G Jacobs, H Hilda Ampadu, Jarno Hoekman, et al.
Journal of Pharmaceutical Policy and Practice
|
April 26, 2014
National medicines policies - a review of the evolution and development processes
Joëlle M Hoebert, Liset van Dijk, Aukje K Mantel-Teeuwisse, et al.
British Journal of Clinical Pharmacology
|
August 26, 2004
Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands
Aukje K Mantel-Teeuwisse, W M Monique Verschuren, Olaf H Klungel, et al.
Journal of Pain and Symptom Management
|
May 28, 2013
Consensus building on access to controlled medicines: a four-stage Delphi consensus procedure
Saskia Jünger, Sarah Brearley, Sheila Payne, et al.
Health Policy (Amsterdam, Netherlands)
|
March 23, 2022
A critical review of methodologies used in pharmaceutical pricing policy analyses
Iris R Joosse, David Tordrup, Lisa Bero, et al.
Page
of 29
Search research articles
Search
Showing results (111-120 of 284) with videos related to
Sort By:
Page
of 29
Pharmacoepidemiology and Drug Safety
|
November 22, 2016
Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment
Evans L Sagwa, Patrick C Souverein, Inês Ribeiro, et al.
Pharmacoeconomics
|
October 5, 2024
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability
Marcelien H E Callenbach, Rick A Vreman, Christine Leopold, et al.
Journal of Pharmaceutical Policy and Practice
|
January 11, 2024
Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children
E Petro, V Perumal-Pillay, A K Mantel-Teeuwisse, et al.
International Journal of Environmental Research and Public Health
|
November 13, 2020
Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis
Rick A Vreman, Thomas F Broekhoff, Hubert Gm Leufkens, et al.
Drug Safety
|
March 23, 2011
Today's challenges in pharmacovigilance: what can we learn from epoetins?
Hans C Ebbers, Aukje K Mantel-Teeuwisse, Ellen H M Moors, et al.
BMC Public Health
|
December 20, 2018
The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study
Tom G Jacobs, H Hilda Ampadu, Jarno Hoekman, et al.
Journal of Pharmaceutical Policy and Practice
|
April 26, 2014
National medicines policies - a review of the evolution and development processes
Joëlle M Hoebert, Liset van Dijk, Aukje K Mantel-Teeuwisse, et al.
British Journal of Clinical Pharmacology
|
August 26, 2004
Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands
Aukje K Mantel-Teeuwisse, W M Monique Verschuren, Olaf H Klungel, et al.
Journal of Pain and Symptom Management
|
May 28, 2013
Consensus building on access to controlled medicines: a four-stage Delphi consensus procedure
Saskia Jünger, Sarah Brearley, Sheila Payne, et al.
Health Policy (Amsterdam, Netherlands)
|
March 23, 2022
A critical review of methodologies used in pharmaceutical pricing policy analyses
Iris R Joosse, David Tordrup, Lisa Bero, et al.
Page
of 29